ABVX
Price
$10.00
Change
-$0.14 (-1.38%)
Updated
Jul 22, 04:59 PM (EDT)
Capitalization
665.08M
19 days until earnings call
KPRX
Price
$3.03
Change
-$0.06 (-1.94%)
Updated
Jul 22, 04:59 PM (EDT)
Capitalization
9.22M
Interact to see
Advertisement

ABVX vs KPRX

Header iconABVX vs KPRX Comparison
Open Charts ABVX vs KPRXBanner chart's image
Abivax SA
Price$10.00
Change-$0.14 (-1.38%)
Volume$3.2K
Capitalization665.08M
Kiora Pharmaceuticals
Price$3.03
Change-$0.06 (-1.94%)
Volume$2.93K
Capitalization9.22M
ABVX vs KPRX Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. KPRX commentary
Jul 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Buy and KPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 23, 2025
Stock price -- (ABVX: $10.14 vs. KPRX: $3.09)
Brand notoriety: ABVX and KPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 340% vs. KPRX: 7%
Market capitalization -- ABVX: $665.08M vs. KPRX: $9.22M
ABVX [@Biotechnology] is valued at $665.08M. KPRX’s [@Biotechnology] market capitalization is $9.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileKPRX’s FA Score has 2 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • KPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, KPRX is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 5 TA indicator(s) are bullish while KPRX’s TA Score has 3 bullish TA indicator(s).

  • ABVX’s TA Score: 5 bullish, 4 bearish.
  • KPRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABVX is a better buy in the short-term than KPRX.

Price Growth

ABVX (@Biotechnology) experienced а +14.84% price change this week, while KPRX (@Biotechnology) price change was +0.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.09%. For the same industry, the average monthly price growth was +19.23%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

ABVX is expected to report earnings on Aug 11, 2025.

KPRX is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+7.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($665M) has a higher market cap than KPRX($9.22M). ABVX YTD gains are higher at: 38.525 vs. KPRX (-6.364). KPRX has higher annual earnings (EBITDA): -9.57M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. KPRX (24.1M). KPRX has less debt than ABVX: KPRX (159K) vs ABVX (92.6M). ABVX (0) and KPRX (0) have equivalent revenues.
ABVXKPRXABVX / KPRX
Capitalization665M9.22M7,210%
EBITDA-170.04M-9.57M1,777%
Gain YTD38.525-6.364-605%
P/E RatioN/A3.67-
Revenue00-
Total Cash104M24.1M432%
Total Debt92.6M159K58,239%
FUNDAMENTALS RATINGS
KPRX: Fundamental Ratings
KPRX
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXKPRX
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSPR0.990.07
+7.12%
MSP Recovery Inc
BEKE19.040.25
+1.33%
KE Holdings
DWTX4.81-0.02
-0.41%
Dogwood Therapeutics Inc
NHI70.15-0.34
-0.48%
National Health Investors
BRY3.10-0.08
-2.52%
Berry Corp

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with SYRE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+1.91%
SYRE - ABVX
40%
Loosely correlated
+0.37%
MLTX - ABVX
39%
Loosely correlated
+0.90%
CGON - ABVX
38%
Loosely correlated
+0.56%
XENE - ABVX
38%
Loosely correlated
-0.32%
DYN - ABVX
37%
Loosely correlated
+1.66%
More

KPRX and

Correlation & Price change

A.I.dvisor tells us that KPRX and PRME have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KPRX and PRME's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
-2.83%
PRME - KPRX
32%
Poorly correlated
+10.65%
SYRE - KPRX
31%
Poorly correlated
+0.37%
ABVX - KPRX
31%
Poorly correlated
+1.91%
CGEN - KPRX
31%
Poorly correlated
-1.95%
RCUS - KPRX
31%
Poorly correlated
+1.20%
More